Stock comparison
BlackRock Technology and Private Equity Term
IDEXX Laboratories
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BTX
BlackRock Technology and Private Equity Term
Market cap
$1.04B
Sector
Healthcare
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BTX | IDXX | Winner |
|---|---|---|---|
| Warren Buffett | 44D | 75B | IDXX |
| Benjamin Graham | 46D | 80A | IDXX |
| Philip Fisher | 62C | 75B | IDXX |
| Peter Lynch | 56C | 71B | IDXX |
| Joel Greenblatt | 44D | 83C | IDXX |
| Charlie Munger | 41D | 87A | IDXX |
| Terry Smith | 45D | 84A | IDXX |
Side-by-side metrics
| Metric | BTX | IDXX |
|---|---|---|
| Market cap | $1.04B | $44.12B |
| P/E (TTM) | 50.0x | 39.0x |
| EV/EBIT | 27.0x | 31.6x |
| ROIC (TTM) | 3.85% | 40.66% |
| Gross margin | 100.0% | 62.05% |
| Net margin | 87.75% | 24.63% |
| Revenue CAGR 5y | - | 7.56% |
| EPS CAGR 5y | - | 10.79% |
| Debt / Equity | - | 0.7x |
| Dividend yield | 9.29% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BTX leads on
- Debt / Equity-vs 0.7x+100%
- Dividend yield9.29%vs 0.0%+100%
- Net margin87.75%vs 24.63%+72%
- Gross margin100.0%vs 62.05%+38%
IDXX leads on
- Market cap$44.12Bvs $1.04B+98%
- ROIC (TTM)40.66%vs 3.85%+91%
- P/E (TTM)39.0xvs 50.0x+22%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.